Rpn2 Inhibitors
Rpn2 inhibitors are a class of chemical compounds that target the Rpn2 subunit of the 26S proteasome, a crucial component of the ubiquitin-proteasome system responsible for protein degradation in eukaryotic cells. The Rpn2 subunit plays a significant role in recognizing and unfolding ubiquitinated proteins, preparing them for degradation by the proteasome's catalytic core. By inhibiting Rpn2, these compounds interfere with the proteasome's ability to process and degrade proteins, leading to the accumulation of polyubiquitinated proteins within the cell. This disruption can affect various cellular processes, including cell cycle progression, signal transduction, and apoptosis regulation.
Chemically, Rpn2 inhibitors encompass a diverse range of molecules, often designed to interact specifically with the Rpn2 subunit's binding sites. These inhibitors may consist of small organic molecules with high affinity for Rpn2, featuring functional groups that facilitate strong hydrogen bonding, hydrophobic interactions, or covalent attachment to the target protein. Structural studies using techniques like X-ray crystallography and nuclear magnetic resonance have been instrumental in elucidating the binding modes of these inhibitors, revealing critical insights into their molecular interactions with Rpn2. By understanding these interactions, researchers can optimize the inhibitors' chemical structures to enhance their specificity and potency. The development of Rpn2 inhibitors continues to advance, contributing to a deeper understanding of proteasome regulation and protein homeostasis within cells.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may repress Rpn2 expression by interfering with the transcription of proteasome subunit genes, potentially through inhibition of specific transcription factors responsible for Rpn2 transcription. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib could decrease Rpn2 expression as a secondary effect of proteasome inhibition, which might lead to the stabilization of proteins that repress the transcription of proteasome-related genes. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol might contribute to the reduction in Rpn2 expression by eliciting a heat shock response that alters the transcriptional machinery responsible for the expression of proteasome subunits. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate may decrease Rpn2 expression by downregulating the expression of genes encoding the proteasome complex, possibly through the attenuation of specific cell signaling cascades involved in gene transcription. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram could inhibit Rpn2 expression by chelating metal ions necessary for the proper function of metal-dependent transcription factors that drive Rpn2 gene expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 might reduce Rpn2 expression by causing the accumulation of ubiquitinated proteins, leading to a compensatory decrease in the transcription of proteasome subunits, including Rpn2. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could lead to decreased Rpn2 expression by repressing the nuclear translocation and binding activity of transcription factors such as NF-κB, which are involved in the transcriptional control of the Rpn2 gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might downregulate Rpn2 expression by disrupting specific cell signaling pathways that govern the expression of genes encoding proteasome components. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane may reduce Rpn2 expression by activating transcriptional pathways that enhance the transcription of genes involved in cellular defense mechanisms, potentially at the expense of genes like Rpn2. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A could lead to the downregulation of Rpn2 expression by causing structural modifications in the proteasome assembly, which may trigger a negative feedback loop that diminishes the expression of proteasome subunits. | ||||||